Related references
Note: Only part of the references are listed.Gastric marginal zone lymphoma of MALT type: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
E. Zucca et al.
ANNALS OF ONCOLOGY (2013)
Eradication Therapy in Helicobacter pylori-negative, Gastric Low-grade Mucosa–associated Lymphoid Tissue Lymphoma Patients
Angelo Zullo et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2013)
Addition of Rituximab to Chlorambucil Produces Superior Event-Free Survival in the Treatment of Patients With Extranodal Marginal-Zone B-Cell Lymphoma: 5-Year Analysis of the IELSG-19 Randomized Study
Emanuele Zucca et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Second Cancers and Residual Disease in Patients Treated for Gastric Mucosa-Associated Lymphoid Tissue Lymphoma by Helicobacter pylori Eradication and Followed for 10 Years
Thomas Wuendisch et al.
GASTROENTEROLOGY (2012)
Long-term clinical outcome of gastric MALT lymphoma after eradication of Helicobacter pylori: a multicentre cohort follow-up study of 420 patients in Japan
Shotaro Nakamura et al.
GUT (2012)
EGILS consensus report. Gastric extranodal marginal zone B-cell lymphoma of MALT
A. Ruskone -Fourmestraux et al.
GUT (2011)
Outcome and Quality of Life Favour a Conservative Treatment of Patients with Primary Gastric Lymphoma
W. Fischbach et al.
ZEITSCHRIFT FUR GASTROENTEROLOGIE (2011)
Effects of Helicobacter pylori Eradication on Early Stage Gastric Mucosa-Associated Lymphoid Tissue Lymphoma
Angelo Zullo et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2010)
Long-term outcome following Helicobacter pylori eradication in a retrospective study of 105 patients with localized gastric marginal zone B-cell lymphoma of MALT type
A. Stathis et al.
ANNALS OF ONCOLOGY (2009)
Gastric MALT lymphoma: Epidemiology and high adenocarcinoma risk in a nation-wide study
L. G. Capelle et al.
EUROPEAN JOURNAL OF CANCER (2008)
Most patients with minimal histological residuals of gastric MALT lymphoma after successful eradication of Helicobacter pylori can be managed safely by a watch and wait strategy:: experience from a large international series
W. Fischbach et al.
GUT (2007)
Clinical impact of genetic aberrations in gastric MALT lymphoma:: a comprehensive analysis using interphase fluorescence in situ hybridisation
Shotaro Nakamura et al.
GUT (2007)
Long-term follow-up of gastric MALT lymphoma after Helicobacter pylori eradication
T Wündisch et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication therapy: experience from a large prospective series
W Fischbach et al.
GUT (2004)
T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H-pylori eradication
HX Liu et al.
GASTROENTEROLOGY (2002)
Predictive factors for regression of gastric MALT lymphoma after anti-Helicobacter pylori treatment
A Ruskoné-Fourmestraux et al.
GUT (2001)
Share Paper
